Loading…

Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients

The mechanisms of thrombogenicity in essential thrombocythemia (ET) are complex and not well defined. Our objective was to explore whether phosphatidylserine (PS) exposure on blood cells and endothelial cells (ECs) can account for the increased thrombosis and distinct thrombotic risks among mutation...

Full description

Saved in:
Bibliographic Details
Published in:Annals of hematology 2018-04, Vol.97 (4), p.605-616
Main Authors: Tong, Dongxia, Yu, Muxin, Guo, Li, Li, Tao, Li, Jihe, Novakovic, Valerie A., Dong, Zengxiang, Tian, Ye, Kou, Junjie, Bi, Yayan, Wang, Jinghua, Zhou, Jin, Shi, Jialan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The mechanisms of thrombogenicity in essential thrombocythemia (ET) are complex and not well defined. Our objective was to explore whether phosphatidylserine (PS) exposure on blood cells and endothelial cells (ECs) can account for the increased thrombosis and distinct thrombotic risks among mutational subtypes in ET. Using flow cytometry and confocal microscopy, we found that the levels of PS-exposing erythrocytes, platelets, leukocytes, and serum-cultured ECs were significantly higher in each ET group [JAK2, CALR, and triple-negative (TN) (all P  
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-018-3228-6